|
Post-Surgical
Palliation Home Surveillance
DeeAnn Martin, R.N.; Cardiac
Surgery Speciality Nurse, Arkansas Children's Hospital
Hypoplastic left heart syndrome (HLHS) is a
constellation of defects involving stenosis or atresia of
the mitral valve, hypoplasia of the systemic or left ventricle,
severe aortic valve hypoplasia with atresia, and hypoplasia
of the ascending aorta. Surgical palliation for infants born
with HLHS consists of Stage 1 Palliation (S1P). Also
known as the Norwood procedure, S1P is the construction
of an unobstructed outlet for systemic cardiac output
from the right ventricle, and adequate pulmonary blood
flow through a controlled shunt.
In the recent past, late interim mortality
between S1P and Stage 2 Palliation (S2P) ranged from 10 percent
to 15 percent. The Norwood population is considered
to be at increased risk for sudden death from a combination
of physiologic variances. Worsening systemic oxygenation
and acute dehydration are variables which contribute to increased
risk for sudden death. Home surveillance programs,
consisting of daily oxygen saturation monitoring and weight
checks, have been shown to decrease the risk of late interim
mortality between S1P and S2P from 10 percent to 15 percent
to 0 percent for infants with HLHS.
History of the Program
Since 2002, the ACH Cardiac Surgery department has
monitored each post-Norwood baby with a home surveillance
program. Beginning in 2006, the program was expanded to
include all babies with univentricular hearts palliated
with systemic to pulmonary artery shunts. Home pulse oximeters
and baby scales are provided by the family’s insurance
company and placed in each baby’s home. The primary
caregiver is taught how to correctly obtain an accurate
daily oxygen saturation reading and weight. These measurements
are recorded on a provided form and faxed weekly to the
Cardiac Surgery department.
Each baby’s growth and oxygen saturation
trends are monitored closely. This information is provided
to the baby’s primary cardiologist and a registered
dietician participating in the program. Thus ongoing
assessment of each palliated infant is achieved by three
collaborating services. Patient participation in the
home surveillance program ceases with achievement of stage
2 palliation.
Obtaining home monitoring equipment is becoming
difficult as more third-party payers are denying coverage. Therefore,
ACH CVICU is providing baby scales as needed for caregivers’ use. We
would be remiss if, after performing advanced surgical intervention
and postoperative care, we did not enable the primary caregivers
to continue high quality care for their babies. We are committed
to reducing interim morbidity and mortality, thus optimizing
each palliated baby’s life course.
Back to
Top
Advanced
Practice Nursing at Arkansas Children's Hospital
Michelle
McDonnell, APN; CVICU, Arkansas Children's Hospital
An Advanced Practice Nurse (APN) is a registered
nurse who has completed an advanced nursing educational program,
usually at the graduate level, and holds certification from
a nationally recognized certifying body. There are
several specialty areas in which an APN can obtain certification,
including pediatrics. Currently in the Heart Center,
there are five certified Pediatric Nurse Practitioners (PNP),
two of whom have obtained additional certification as Pediatric
Acute Care Nurse Practitioners. All of the current PNPs
obtained their graduate degree from UAMS and have previous
pediatric nursing experience at ACH. In addition to
formal educational training, PNPs in the Heart Center complete
six months of orientation, working closely with an experienced
nurse practitioner to learn the ICU role.
PNPs are able to directly influence patient
care through the medical management of pediatric patients,
monitoring and ensuring the quality of health care
practice and providing family-centered care. In addition,
they influence practice through staff education, consultation,
research and research dissemination. In the Heart Center,
PNPs work in collaboration
with Pediatric Cardiologists and Intensivists in managing
congenital cardiac patients after surgery.
In collaboration with these physicians, PNPs
are able to perform history and physical examinations,
evaluate clinical data and make appropriate medical decisions,
and perform procedures including management and removal
of arterial and central venous lines, venous and arterial
puncture, endotracheal intubation, umbilical catheter
insertion, needle thoracentesis, defibrillation or cardioversion,
removal of chest tubes, pacing wires, and peritoneal catheters, and
lumbar punctures. The CVICU team, composed of the attending
physician, unit
pharmacist and nurse practitioner, evaluates and assesses
each patient and develops a plan of care for the day. In
addition to taking care of all cardiac ICU patients, the
team is also responsible for any cardiac ECMO patients.
The practitioner team is able to cover
the unit seven days a week with some night coverage,
lending continuity to the CVICU team. Interacting with
families and patients on a daily basis enables the
practitioners to facilitate education and discharge planning based
on the individual needs of the patient. In addition,
the practitioner team works closely with other team members
including the unit pharmacist, social worker, child life
specialist, speech/physical/and occupational therapists to
maximize functional abilities and prevent or minimize disabilities.
Back to Top
Pain
Management after Heart Surgery in the Heart Center
Laura Morales, Pharm. D.; Clinical
Coordinator of the Pharmacy, Arkansas Children's Hospital
At Arkansas Children’s Hospital Heart
Center, pain control is a vital element of the
healing process after surgery. The pain response includes
an increase in circulating levels of catecholamines
(adrenalin type chemicals) and hormones leading to tachycardia
(increased heart rate), hypertension (increased blood pressure),
increased oxygen consumption, hypercoagulability (increased
blood clotting), immunosuppression (decreased ability to
fight infection) and catabolism (protein breakdown). Also,
lung recovery can be affected when coughing or physical activity
is delayed due to pain.
All patients, including the tiniest newborns,
receive analgesics (pain medicines) with careful monitoring. Narcotic
analgesics such as morphine or fentanyl are first given in
the operating room prior to surgery and continued afterward.
Doses are adjusted as needed. While intubated (on a breathing
machine), most patients also receive a benzodiazepine such
as midazolam or lorazepam to lessen their anxiety, promote
rest, minimize movement and provide amnesia. Both types of
medications (narcotics and benzodiazepines) may need to be
decreased before extubation (removal of a breathing machine)
as they can suppress the patient’s ability to breath
on their own. A new medication that offers sedation
with some analgesia but without respiratory depression is
dexmedetomidine (Precedex). It is not a narcotic or benzodiazepine
but is an alpha 2 agonist (related to clonidine but more
selective) given as a continuous infusion.
Some patients may be candidates for regional
(or localized) pain control measures such as epidural or
nerve blocks where local anesthetics and/or narcotics are
given into tissue spaces by an anesthesiologist providing
analgesia with fewer side effects.
Pain Management Administering
Intramuscular injections are painful and are not used
for post operative pain control.
Instead,
patients receive analgesics through their IV (or intravenous line) either
as frequent injections or a continuous infusion. When patients are
able to resume intake of liquids, oral pain medications such as acetaminophen
with codeine (Tylenol with codeine) or oxycodone (Percocet) are given routinely
around the clock or on an as needed basis, depending on the comfort level
of the patient. Constipation is common and can be treated or prevented
with laxatives.
Patients 8 years or older may be candidates
for “PCA” (or patient controlled analgesia).
A special IV pump is programmed so the patient can push a
button at their bedside allowing the pump to give an IV dose
of analgesic (usually morphine) every few minutes. Sometimes,
this is in addition to a small continuous infusion called
a background dose. This allows the patient to be more in
control of their analgesia once they have awakened from general
anesthesia and are alert. Ketorolac (Toradol) is an analgesic
similar to ibuprofen (Motrin) but given through IV.
It is useful in patients who are extremely sleepy or nauseated
from narcotics. Ketorolac is FDA approved for use (in single
doses) in patients over 2 years of age. Patients must be
stable from risks of bleeding with normal renal function
for ketorolac to be considered.
Patients who are critically ill and remain
intubated for over a week while receiving morphine, fentanyl,
midazolam or lorazepam can develop tolerance to these agents.
Thus, increased doses are needed to provide the same effect
as before. However, once patients are improving, these agents
can be weaned with dosages decreased slowly to prevent withdrawal
symptoms of irritability, tremor, vomiting, sweating, fever
or diarrhea. This is termed “physical dependence” and
occurs in all patients, regardless of age, who receive these
agents for prolonged periods. We treat this by tapering morphine
or fentanyl and/or switching to an equivalent dose of oral
methadone. IV midazolam or lorazepam doses are converted
to oral lorazepam. Doses are decreased every few days
and patients are monitored for any further symptoms.
About Addiction
Tolerance and physical dependence alone do not define “addiction,” which
parents may be concerned about until they are educated on
the difference. Addiction is a chronic disease, with behaviors
of using a substance in the face of adverse consequences
with loss of control (compulsive use) and a preoccupation
with use (cravings). Genetic, psychosocial and environmental
factors must all co-exist for addiction to occur in any individual.
It is not uncommon to see physical dependence and tolerance
from a prolonged recovery, but addiction is quite rare. Emotional
distress from inadequate analgesia is not something we want
our patients or parents to experience. Pain-free recovery
after major surgery is not a reality yet, but minimizing
discomfort for our patients is certainly achievable now.
Back to Top
What
is Transposition of the Great Arteries?
Michiaki Imamura, M.D., Ph.D.; Pediatric
Cardiac Surgeon, Arkansas Children's Hospital; Assistant
Professor, Department of Surgery, University of Arkansas
for Medical Sciences College of Medicine
Our hearts have four chambers inside them (Fig.
1). Under normal conditions, the blood from the body comes
back to the heart into the right atrium. This blood is relatively
blue (deoxygenated) blood. This blue blood goes to the right
ventricle, which pumps the blood to the lungs through the
pulmonary artery. In the lungs, this blood becomes red (oxygenated)
blood and returns to the left atrium. This red blood goes
to the left ventricle which pumps it to the whole body through
the aorta. The aorta and the pulmonary artery, the two major
arteries carrying blood away from the heart, are referred
to as the “Great Arteries.”
However, in a patient with transposition of
the Great Arteries, the aorta and the pulmonary artery are
switched, and these vessels arise from the wrong ventricle
(Fig. 2). Therefore, blue blood comes back from the body
and goes to the body again, while the red blood comes back
from the lungs and goes to the lungs again.
In the case of transposition of the great arteries,
additional intracardiac anomalies occur, such as ventricular
septal defect, pulmonary valve stenosis, pulmonary artery
stenosis, aortic stenosis, coarctation of the aorta, hypoplasia
of the aortic arch and interrupted aortic arch. In the presence
of a ventricular septal defect and pulmonary valve stenosis,
a different surgical treatment is required. The ventricular
septal defect is the most common additional anomaly, except
for patent duct arteriosus and an atrial septal defect. In
the presence of other anomalies, treatment is chosen for
transposition of the great arteries.
Signs and Symptoms
Babies with transposition are usually diagnosed as
neonates due to cyanosis – blue coloring of skin,
lips and nails. Cyanosis develops in the presence of poor
oxygenation of the red blood cells. Occasionally, a baby
with transposition receives a large amount of pulmonary
blood flow and does not show prominent cyanosis. Without
surgical intervention, more than half of infants with transposition
will die in the first month of life, and 90 percent will
die in the first year.
Diagnosing
Definitive diagnosis is made by echocardiography. Recently,
many patients have been diagnosed before birth by fetal
echocardiography.
Treatment
If there is no shunting (septal defects) inside the
heart, a baby with this disease is not able to survive.
This shunting generally occurs due to a hole between atriums
(an ASD). However, some babies do not have this shunt,
which makes their early diagnosis critical in order to
prevent early death. In order to obtain adequate mixing
inside the heart, a hole between the right and left atrium
is created or enlarged. This procedure is done by a cardiologist,
who passes a small balloon through a large vein into the
heart.
Historically, several surgical interventions
are applied to this disease. In 1959, Dr. Senning invented
the new technique of atrial level switching (Fig. 3).
In 1963, Dr. Mustard invented a surgery similar
to Dr. Senning’s, using a patch to reroute inside the
atrium. After these surgeries, the babies are no longer blue
or cyanotic. After this surgery, most patients fared well
for a period of time. However, some patients developed severe
heart failure (heart pumping ability problems) or severe
arrhythmia (a heart beating/rhythm problem). This disappointing
result was prominent in the presence of a ventricular septal
defect.
In 1975, Dr. Jatene succeeded with the first
arterial switch operation for transposition. This surgery
has two components. One involves the switching of the great
arteries, followed by moving the coronary arteries. Switching
the great arteries means swapping the aorta and the pulmonary
artery (Fig. 4). The coronary arteries are the blood vessels
which bring the blood to the heart itself. In a neonate,
the great arteries are sized 1 to 1.5 centimeters in diameter.
However, the coronary arteries are only 1 to 2 millimeters
in diameter. At the time of surgery, these coronary arteries
are removed from the aorta with a cuff of tissue of 5 to
7 millimeters. Then this cuff will be anastomosed to the
original pulmonary artery. Additional anomalies of ventricular
septal defects, atrial septal defects and arch anomalies
are repaired as part of the operation.
Risk factors for an arterial switch operation
involve coronary anomalies, including a single coronary,
intramural coronary and unusual coronary patterns. In the
presence of certain cardiac anomalies, such as pulmonary
valve stenosis or left ventricular outflow tract obstruction,
an arterial switch operation is not chosen as the treatment
for transposition.
When the patient has a large ventricular septal
defect with pulmonary valve stenosis, a Rastelli type surgery
is instituted. A Rastelli type of surgery is composed of
ventricular septal defect closure, and rerouting of the left
ventricle to the original aortic valve, and placement of
a conduit (or tube) between the right ventricle and the pulmonary
artery (Fig. 5, 6). This type of surgery has several deficits.
First, the patient will require conduit replacement periodically,
secondary to obstruction over time. Secondly, in the presence
of small ventricular septal defect, the patient may develop
left ventricular outflow tract obstruction, which may necessitate
further surgical interventions, as well.
Treatment Results
In the majority of cardiovascular centers, the surgical
mortality of arterial switch operation is less than 5 percent.
The patients with the above mentioned risk factors have
a higher mortality rate after arterial switch operations.
Since the left ventricle is used as a systemic ventricle,
after arterial switch operations children usually have normal
ventricular functions and no heart rhythm abnormalities.
However, late morbidities include neo aortic valve
insufficiency, left ventricular outflow tract obstruction
and coronary insufficiency.
Back to Top
Spotlight
on Jim Bodtke, RDCS
Cardiac Sonographer, Arkansas Children's Hospital
What is your role at ACH and how long have
you worked here?
My role at ACH is to provide cardiac echos for our
physicians. I started here part time in 2002, and
became full time soon after.
Why is your job rewarding?
The rewards for me here at ACH come from many different
avenues. They range greatly, from experiencing the
grasp of a child’s hand, to a hug for a job well
done, to just being a witness to the love that is freely
given by the staff here at ACH.
How did you become interested
in pediatric cardiology or cardiovascular surgery?
I used to work in an adult lab, but rarely felt that
I was making a great impact on a patient’s outcome,
nor did it offer me the variety that pediatrics could. I
became exposed to pediatric cardiology at another institution
and immediately knew what I wanted to do each day.
What do you want people to know about
the Heart Center at Arkansas Children's Hospital?
I would want them to know all the people that are part
of the Heart Center are here for one reason only: Not
out of the need for a job, but because they share a common
bond, and that is the children that come here for care, and
that they give that care unselfishly.
What do you enjoy most about working
with children?
That’s the easiest question to answer: Making them
smile. If you can achieve getting a pediatric patient
to flash you a smile, even briefly, you know you have made
a difference in their day. Besides, for me, that is
the easiest part, as well. I stay pretty much on a child’s
level most of the time.
What has been your most memorable moment
working in the Heart Center at Arkansas Children's Hospital?
The first time I saw a patient without much chance
at survival make a full recovery after receiving a heart
transplant. This was the first time that I felt I was
part of something bigger than myself, or even all of us together. Along
with that came the realization that as long as I remain here,
I will get to witness this over and over again.
What is your greatest professional
achievement?
Sitting in a lab in Leuven, Belgium, with their world-renowned
researchers and realizing that the research that we are doing
at ACH is on par with theirs. Little Rock, Arkansas – who
would have thought?
Jim Bodtke has been instrumental in setting up a new
research study in the Heart Station. His study evaluated
strain/strain rate analysis of the left ventricular myocardium
of transplant patients, as an early indicator of cardiac
transplant rejection. Strain/strain rates allow the
cardiologist to study the deformation of the heart in a
process over time. Strain and strain rate is
a new technology in echocardiography that has had very
limited pediatric study.
Bodtke enrolled 46 patients within his study and has
examined these results collectively with several cardiologists in
the ACH Heart Station. In addition to Bodtke’s study,
several cardiologists have also begun studies utilizing
this data and its significance to cardiac transplant rejection.
Jim has been dedicated to achieving our long-term goals
of excellence in pediatric echocardiography research.
Sherrie Loyd
Director, Ambulatory Cardiac Services
Cardiology Clinic, Heart Station
Cardiac Cath Lab/Electrophysiology Lab
Arkansas Children’s Hospital
Back to Top
|